Haşmet Hanağası

Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to <i>ATP13A2, PLA2G6, FBXO7</i> and <i>spatacsin</i> mutations

Coro Paisán-Ruı́z, Rocio Guevara, Monica Federoff et al. · Movement Disorders · 2010 · 249 citations

Life Sciences, Genetics, Neurology +15

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Erdinç Dursun, Duygu Gezen‐Ak, Haşmet Hanağası et al. · Journal of Neuroimmunology · 2015 · 230 citations

Medicine, Immunology, Neurology +17

BDNF, TNFα, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment

Duygu Gezen‐Ak, Erdinç Dursun, Haşmet Hanağası et al. · Journal of Alzheimer s Disease · 2013 · 185 citations

Life Sciences, Neurology, Neuroscience +17

Association between Vitamin D Receptor Gene Polymorphism and Alzheimer's Disease

Duygu Gezen‐Ak, Erdinç Dursun, Turan Ertan et al. · The Tohoku Journal of Experimental Medicine · 2007 · 145 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials

Haşmet Hanağası, Hakan Gürvıt, Numan Ermutlu et al. · Cognitive Brain Research · 2002 · 141 citations

Life Sciences, Neurology, Neuroscience +17